Silvia Cernea Clark

The Rice lab of bioengineer Gang Bao and collaborators at Baylor College of Medicine have developed a new gene-editing strategy that dramatically boosts the effectiveness of gene therapies in the liver, a breakthrough that could lead to new

Rice bioengineers have developed a new construction kit for building custom sense-and-respond circuits in human cells. The research is a major breakthrough that could revolutionize therapies for complex conditions like autoimmune disease and cancer.

A team of Rice bioengineers has developed a mathematical model that clarifies why interleukin-12 ⎯ a potent immune-boosting protein that holds promise for cancer treatment ⎯ loses effectiveness over time when used as an immunotherapeutic.

Rice bioengineer Kevin McHugh has been awarded $3.4 million for a project to incorporate protection against polio into the combination vaccine that protects against five common and dangerous childhood diseases.

Rice scientists and collaborators at Texas A&M University and University of Texas MD Anderson Cancer Center have found a new way to kill cancer cells by using near-infrared light to make a small dye molecule attached to their membrane vibrate

Rice bioengineers developed a tool that activates silent or insufficiently expressed genes using human-derived building blocks and a CRISPR-based genome-targeting platform.

Rice scientists mapped out the three-dimensional structure of one of the smallest known CRISPR-Cas13 systems then used that knowledge to modify its structure and improve its accuracy.

To make a gene-editing tool more precise and easier to control, Rice University engineers split it into two pieces that only come back together when a third molecule is added.

Rice U. bioengineers developed a platform that enhances survival and function of probiotics engineered to diagnose inflammatory bowel disease in animals. The technology holds promise for minimally invasive disease monitoring and advanced smart

Rice University bioengineer Gang Bao and his team have won a grant from the National Institutes of Health to address critical questions surrounding the safety and efficacy of using gene editing to treat sickle cell disease.

Rice University chemist Han Xiao has won a $3.2 million research project (R01) grant from the National Cancer Institute to develop the first tissue-specific epigenetic inhibitor drug to treat bone metastasis.

A new study by Rice University bioscientists explains how structures inside plant cells collaborate to fuel germination. The findings could shed light on corresponding mechanisms in human cells.

Rice University scientists have used light-activated molecular machines to induce cell-to-cell calcium signaling, revealing a powerful new strategy for drug design. This technology could lead to improved treatments for people with heart problems,

Retracing nature’s steps, Rice University engineer Xue Gao and her team mapped out the full series of enzyme-powered reactions a marine fungus uses to produce a complex molecule with anticancer properties. In the process, the Gao lab uncovered the

Rice U. chemist Anatoly Kolomeisky has won a National Science Foundation award to study the role of heterogeneity in chemical and biological processes.

Rice U.’s Aryeh Warmflash wins $1.9 million NIH grant to develop experimental cell models that can shed light on critical embryonic developmental processes.

Rice University scientists identified three biomaterial formulations that could help develop a more sustainable, long-term, self-regulating way to treat Type 1 diabetes using a new screening technique that involves tagging each biomaterial

Rice U. bioengineers have developed an upgraded tumor model that houses bone cancer cells beside immune cells inside a 3D structure engineered to mimic bone and, through research using the model, found that the body’s immune response can make tumor

Rice University bioengineer Omid Veiseh and collaborators found that lipid deposition on the surfaces of medical implants can play a mediating role between the body and implants, knowledge that could help scientists develop biomaterials or coatings

Rice University scientists enlist widely used cancer therapy systems to control gene expression in mammalian cells, a feat of synthetic biology that could change how diseases are treated.